Corgenix Medical Corporation Featured in KonLin Letter.DENVER -- Corgenix Medical Corporation (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :CONX), a worldwide marketer of diagnostic test kits, has been featured in the October 2005 issue of the KonLin Letter. The Konlin Letter specializes in featuring low-priced and under-followed stocks, as well as places emphasis on emerging growth and special situations poised for price appreciation. The letter may be obtained by visiting www.KonLin.com. About Corgenix Medical Corporation Corgenix is a leader in the development and manufacturing of specialized diagnostic kits for immunology immunology, branch of medicine that studies the response of organisms to foreign substances, e.g., viruses, bacteria, and bacterial toxins (see immunity). Immunologists study the tissues and organs of the immune system (bone marrow, spleen, tonsils, thymus, lymphatic disorders, vascular diseases vascular diseases, n.pl diseases of the peripheral circulatory system. and bone and joint disorders. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. The company currently sells over 50 diagnostic products through a global distribution network and has significant experience advancing products through the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. process. More information is available at www.corgenix.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion